Marín-Fernández AB, García Medina B,
Aguilar-Salvatierra A, Jiménez-Burkhardt
A, Gómez-Moreno G.
Jaw osteonecrosis management around a dental implant
inserted 2 years before starting treatment with zoledronic
acid. J Clin Exp Dent.
2015;7(3):e444-6.
doi:10.4317/jced.52234
References
1. Gómez-Moreno G, Arribas-Fernández
MC, Fernández-Guerrero M, Boquete-Castro A, Aguilar-Salvatierra A, Guardia J,
et al. Bisphosphonate-associated osteonecrosis of the jaw 2 years
after teeth extractions: a case report solved with non-invasive treatment. Eur Rev Med Pharmacol
Sci. 2014;18:1391-7. |
|
2. Body JJ. Breast
cancer: bisphosphonate therapy for metastasic bone disease. Clin Cancer Res. 2006;12:6258-63. |
|
|
|
3. Bagan
JV, Jimenez Y, Diaz JM,
Murillo J, Sanchis JM, Poveda
R, et al. Osteonecrosis of the jaws in intravenous bisphosphonate
use: Proposal for a modification of the clinical classification. Oral Oncol. 2009;45:645-6. |
|
|
|
4. Gnant M. Zoledronic acid in
breast cancer: latest findings and interpretations. A review. Ther Adv Med Oncol. 2011;3:293-301. |
|
|
|
5. Soolari N, Soolari A. Closure
of an open wound associated with bisphosphonate-related
osteonecrosis of the jaw in a breast cancer
patient. Open Dent J. 2011;5:163-7. |
|
|
|
6. Bagán
J, Blade J, Cozar JM,
Constela M, García Sanz R, Gómez Veiga F, et al. Recommendations for the prevention,
diagnosis, and treatment of osteonecrosis of the
jaw (ONJ) in cancer patients treated with bisphosphonate.
Med Oral Patol Oral Cir Bucal. 2007;12:336-40. PMid:17664922 |
|
|
|
7. Favia G, Piattelli A, Sportelli P, Capodiferro S, Iezzi G. Osteonecrosis of the
posterior mandible after implant insertion: a clinical and histological case
report. Clin Impl Dent
and Relat Res. 2011;13:58-63. |
|
|
|
8. Merigo
E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E, et al. Bone necrosis of the jaws associated
with bisphosphonate treatment: a report of
twenty-nine cases. Acta Biomed.
2006;77:109-17. |
|
|
|
9. Bamias
A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I,
Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment
with bisphosphonates: incidence and risk factors. J Clin Oncol.
2005;23:8580-7. |